Home › Cancer (all types) › Washington › Kirkland
Cancer (all types) clinical trials in Kirkland, WA
4 studies for Cancer (all types) are looking for participants at sites in and around Kirkland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
RecruitingPhase 3
- Swedish Cancer Institute-Edmonds, Edmonds · 12 mi away
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- Swedish Cancer Institute - Edmonds, Edmonds · 12 mi away
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Swedish Cancer Institute-Edmonds, Edmonds · 12 mi away
A Study of ASP1002 in Adults for Treatment of Solid Tumors
RecruitingPhase 1
- Swedish Cancer Institute, Edmonds · 12 mi away
About Cancer (all types)
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
More about Cancer (all types) on MedlinePlus
Cancer (all types) trials in other cities
- Houston, TX122 studies
- New York City, NY110 studies
- Boston, MA86 studies
- Los Angeles, CA73 studies
- Nashville, TN65 studies
- Washington, DC60 studies
- Philadelphia, PA60 studies
- Durham, NC59 studies
- Chicago, IL52 studies
- Seattle, WA50 studies
- Atlanta, GA50 studies
- Arlington, VA48 studies
Other studies in Kirkland
- Non-Small Cell Lung Cancer11 studies
- Parkinson's Disease9 studies
- Lung Cancer8 studies
- Colorectal Cancer7 studies
- Breast Cancer7 studies
- Prostate Cancer7 studies
- Acute Myeloid Leukemia6 studies
- Metastatic Cancer6 studies
- Melanoma5 studies
- Ovarian Cancer5 studies
- Atherosclerosis4 studies
- Obesity4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.